Orrick Advises Aledade on $100 Million Series D


Orrick congratulates healthcare technology client Aledade on its $100 million Series D financing round. Returning investor Meritech Capital led the round, along with new investors Tiger Global Management and IVP, and returning investor OMERS Growth Equity. 

Founded in 2014, Aledade partners with independent practices, health centers, and clinics to build and lead Accountable Care Organizations anchored in primary care. Aledade plans to use the new capital to expand its care model with health plans across the country and grow its strategic partnerships. 

The Orrick team advising Aledade was led by Stephen Thau and included Andrew Rembis, Andrew Wallach and Sheila Maguire.